OxAMI - Oxford Acute Myocardial Infarction Study (@oxami_study) 's Twitter Profile
OxAMI - Oxford Acute Myocardial Infarction Study

@oxami_study

ID: 1409442302242787334

linkhttps://oxami.org.uk calendar_today28-06-2021 09:23:40

17 Tweet

35 Followers

15 Following

Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

Proud to have presented at the #EuroPCR PCRonline 🫀 Late Breaking Trials Session my work on angiography-derived IMR (IMRangio) to predict long-term outcome in STEMI in the OxAMI NIHR Oxford Biomedical Research Centre 👉course.europcr.com/vod/non-hypera…

Proud to have presented at the #EuroPCR <a href="/PCRonline/">PCRonline 🫀</a> Late Breaking Trials Session my work on angiography-derived IMR (IMRangio) to predict long-term outcome in STEMI in the OxAMI <a href="/OxfordBRC/">NIHR Oxford Biomedical Research Centre</a> 👉course.europcr.com/vod/non-hypera…
Mayooran Shan (@mayooranshan) 's Twitter Profile Photo

An excellent editorial review (with very valid added suggestions) on OxAMI - Oxford Acute Myocardial Infarction Study paper we recently published. x.com/MayooranShan/s… Coronary Microvascular Dysfunction Assessed by Pressure Wire and CMR A... sciencedirect.com/science/articl… Roberto Scarsini Giovanni Luigi De Maria Rafail Kotronias

Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

(1/6) Breaking Frontiers in Cardiovascular Medicine! Non-hyperemic angiography-derived IMR is prognostically equivalent to IMR for long-term adverse outcomes in STE-ACS. First 🥇head to head study in the field by our team frontiersin.org/articles/10.33… PCRonline 🫀 BCIS TCTMD #PCI #CoronaryIntervention

(1/6) Breaking <a href="/FrontCVMedicine/">Frontiers in Cardiovascular Medicine</a>! Non-hyperemic angiography-derived IMR is prognostically equivalent to IMR for long-term adverse outcomes in STE-ACS. First 🥇head to head study in the field by our team frontiersin.org/articles/10.33… <a href="/PCRonline/">PCRonline 🫀</a> <a href="/BCIS_uk/">BCIS</a> <a href="/TCTMD/">TCTMD</a>  #PCI #CoronaryIntervention
Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

(3/6) -IMRangio was computed using the Medis Imaging QFR platform as recently demonstrated in our live webinar 👉 youtu.be/NlIEWQEmBc4 -Methodology and validation are described in detail in our previous papers link.springer.com/article/10.100… & link.springer.com/article/10.100… International Journal of Cardiovascular Imaging

Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

(4/6) Summary results NH IMRangio is: ✅Diagnostically reliable compared to IMR ✅Prognostically equivalent to IMR ✅Independent predictor of an adverse outcome

(4/6) Summary results
NH IMRangio is:  
✅Diagnostically reliable compared to IMR  ✅Prognostically equivalent to IMR
✅Independent predictor of an adverse outcome
Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

(5/6) Future outlook NH IMRangio can: 📈 adoption of coronary microvascular function assessment in STE-ACS ✅risk stratify patients with STE-ACS ✅be deployed to triage 1) adjunct therapies and 2) dedicated treatment pathways for STE-ACS care

Mayooran Shan (@mayooranshan) 's Twitter Profile Photo

Congrats to @NavAkbar and @Choudhury_Lab for this work showing a mechanism behind the innate immune response post-MI. Pleasure to have contributed to this project via OxAMI - Oxford Acute Myocardial Infarction Study #CardioTwitter European Society of Cardiology Journals

Circulation (@circaha) 's Twitter Profile Photo

#OriginalResearch: #AI-based Virtual Native Enhancement is a contrast-free MRI alternative to LGE for tissue characterization in patients with prior #MI. Qiang Zhang Matt Burrage @mayooranshan Ricardo A Gonzales#AHAJournals ahajrnls.org/3R3a5tH

#OriginalResearch: #AI-based Virtual Native Enhancement is a contrast-free MRI alternative to LGE for tissue characterization in patients with prior #MI. <a href="/QiangZhangAiCmr/">Qiang Zhang</a> <a href="/DrMattBurrage/">Matt Burrage</a> @mayooranshan <a href="/_ragonzales/">Ricardo A Gonzales</a>#AHAJournals ahajrnls.org/3R3a5tH
Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

🚨💫Interventional 🫀 Research Fellowship opportunity University of Oxford OxAMI - Oxford Acute Myocardial Infarction Study programme working closely with Giovanni Luigi De Maria & Prof Banning. Open to clinicians of any grade BJCA 📊 BJCAstarter Fore more info: 👇 DMs for more ℹ️ welcome.🚨 my.corehr.com/pls/uoxrecruit…

Mayooran Shan (@mayooranshan) 's Twitter Profile Photo

Our new paper from the OxAMI - Oxford Acute Myocardial Infarction Study RDM Oxford OUH in JACC Journals lnkd.in/eNkMQcVH Whole heart #whyCMR #T1mapping in #STEMI shows that acute adverse response in the non-infarcted myocardium is associated with the development of #heartfailure at long-term 🧵

Mayooran Shan (@mayooranshan) 's Twitter Profile Photo

Proud to have published this paper from OxAMI - Oxford Acute Myocardial Infarction Study in JACC Journals. #whyCMR performed before invasive coronary angiogram may change management in ~50% of the patients admitted to hospital with suspected #NSTEMI jacc.org/doi/10.1016/j.… British Heart Foundation : bhf.org.uk/what-we-do/new…

Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

📢 Tweetorial: Can Photon-Counting CCTA (PCCTA) Overcome Heavy Coronary Calcification? 🫀📸doi.org/10.1016/j.jcmg… A deep dive into how ultrahigh-resolution PCCTA (UHR-PCCTA) and standard resolution PCCTA (SR-PCCTA) stack up against gold-standard 3D invasive QCA.🧵👇🧵👇

Rafail Kotronias (@rafkotronias) 's Twitter Profile Photo

1/ Background 🚫Current guidelines discourage CCTA in elderly patients or those with heavy coronary calcification due to reduced accuracy. 🔬 Photon-Counting CCTA (PCCTA)—offers ultrahigh resolution & multi-energy imaging. 💡But does it solve the calcification problem?